179 related articles for article (PubMed ID: 27904940)
1. [No evidence for improved outcome with salvage radiotherapy for asymptomatic biochemical prostate cancer recurrence after prostatectomy by additive androgen suppression].
Garcia Schüler H; Guckenberger M
Strahlenther Onkol; 2017 Jan; 193(1):86-88. PubMed ID: 27904940
[No Abstract] [Full Text] [Related]
2. [Salvage radiotherapy with or without short-term hormone suppression for rising PSA levels].
Hermann RM; Christiansen H
Strahlenther Onkol; 2016 Oct; 192(10):741-4. PubMed ID: 27530932
[No Abstract] [Full Text] [Related]
3. Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study.
Mizowaki T; Aoki M; Nakamura K; Yorozu A; Kokubo M; Karasawa K; Kozuka T; Nakajima N; Sasai K; Akimoto T
J Radiat Res; 2015 Jul; 56(4):750-6. PubMed ID: 25910489
[TBL] [Abstract][Full Text] [Related]
4. Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.
Song C; Kang HC; Kim JS; Eom KY; Kim IA; Chung JB; Hong SK; Byun SS; Lee SE
Strahlenther Onkol; 2015 Oct; 191(10):801-9. PubMed ID: 26159555
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.
Servoll E; Sæter T; Vlatkovic L; Nesland JM; Waaler G; Axcrona K
Scand J Urol; 2015 Jun; 49(3):218-23. PubMed ID: 25428750
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy can wait in PSA-only relapse.
Schmidt C
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25122737
[No Abstract] [Full Text] [Related]
7. Risk of biochemical recurrence and timing of radiotherapy in pT3a N0 prostate cancer with positive surgical margin : A single center experience.
Hegemann NS; Morcinek S; Buchner A; Karl A; Stief C; Knüchel R; Corradini S; Li M; Belka C; Ganswindt U
Strahlenther Onkol; 2016 Jul; 192(7):440-8. PubMed ID: 27272660
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up and risk of cancer death after radiation for post-prostatectomy rising prostate-specific antigen.
Swanson GP; Du F; Michalek JE; Hermans M
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):62-8. PubMed ID: 20646861
[TBL] [Abstract][Full Text] [Related]
9. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy.
Geinitz H; Riegel MG; Thamm R; Astner ST; Lewerenz C; Zimmermann F; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1930-7. PubMed ID: 21514736
[TBL] [Abstract][Full Text] [Related]
10. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer.
Joung JY; Kim JE; Kim SH; Seo HK; Chung J; Park WS; Hong EK; Lee KH
BMC Urol; 2015 Aug; 15():82. PubMed ID: 26269129
[TBL] [Abstract][Full Text] [Related]
12. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D
Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):112-8. PubMed ID: 22300563
[TBL] [Abstract][Full Text] [Related]
14. [Management of rising PSA after total prostatectomy].
Zerbib M
Ann Urol (Paris); 2007 Oct; 41 Suppl 3():S73-6. PubMed ID: 18297904
[TBL] [Abstract][Full Text] [Related]
15. Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome.
Malone S; Perry G; Eapen L; Segal R; Gallant V; Dahrouge S; Crook J; Spaans JN
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):699-706. PubMed ID: 17379438
[TBL] [Abstract][Full Text] [Related]
16. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system.
Buskirk SJ; Pisansky TM; Schild SE; Macdonald OK; Wehle MJ; Kozelsky TF; Collie AC; Ferrigni RG; Myers RP; Prussak KA; Heckman MG; Crook JE; Parker AS; Igel TC
J Urol; 2006 Sep; 176(3):985-90. PubMed ID: 16890677
[TBL] [Abstract][Full Text] [Related]
17. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome.
Ng CK; Moussa M; Downey DB; Chin JL
J Urol; 2007 Oct; 178(4 Pt 1):1253-7; discussion 1257. PubMed ID: 17698104
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options for a rising PSA after radical prostatectomy.
Carthon BC; Marcus DM; Herrel LA; Jani AB; Rossi PJ; Canter DJ
Can J Urol; 2013 Jun; 20(3):6748-55. PubMed ID: 23783041
[TBL] [Abstract][Full Text] [Related]
19. Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
Taguchi S; Shiraishi K; Fukuhara H; Nakagawa K; Morikawa T; Naito A; Kakutani S; Takeshima Y; Miyazaki H; Nakagawa T; Fujimura T; Kume H; Homma Y
Radiat Oncol; 2016 Jul; 11():102. PubMed ID: 27475986
[TBL] [Abstract][Full Text] [Related]
20. Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?
Taneja SS
J Urol; 2015 Dec; 194(6):1631-2. PubMed ID: 26582665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
